CY1109208T1 - Μηλεϊκη 3-(2-(διμεθυλαμινο) μεθυλ (κυκλοεξ-1-υλ)) φαινολη και οι κρυσταλλικες μορφες της - Google Patents

Μηλεϊκη 3-(2-(διμεθυλαμινο) μεθυλ (κυκλοεξ-1-υλ)) φαινολη και οι κρυσταλλικες μορφες της

Info

Publication number
CY1109208T1
CY1109208T1 CY20091100706T CY091100706T CY1109208T1 CY 1109208 T1 CY1109208 T1 CY 1109208T1 CY 20091100706 T CY20091100706 T CY 20091100706T CY 091100706 T CY091100706 T CY 091100706T CY 1109208 T1 CY1109208 T1 CY 1109208T1
Authority
CY
Cyprus
Prior art keywords
methyl
malexic
bimethylamino
cycloex
final
Prior art date
Application number
CY20091100706T
Other languages
Greek (el)
English (en)
Inventor
Martin Szelagiewicz
Wolfgang Hell
Raumer Markus Von
Paul Susan Margaret De
Jörg Berghausen
Michael Gruss
Original Assignee
Grünenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grünenthal GmbH filed Critical Grünenthal GmbH
Publication of CY1109208T1 publication Critical patent/CY1109208T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CY20091100706T 2005-07-22 2009-07-03 Μηλεϊκη 3-(2-(διμεθυλαμινο) μεθυλ (κυκλοεξ-1-υλ)) φαινολη και οι κρυσταλλικες μορφες της CY1109208T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005034974A DE102005034974A1 (de) 2005-07-22 2005-07-22 Salz von Dimethylaminomethyl-phenyl-cyclohexan und dessen kristalline Formen
EP06776325A EP1881956B1 (de) 2005-07-22 2006-07-20 3-(2-(dimethylamino)methyl-(cyclohex-1-yl))phenol-maleat und dessen kristalline formen

Publications (1)

Publication Number Publication Date
CY1109208T1 true CY1109208T1 (el) 2014-07-02

Family

ID=37084866

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100706T CY1109208T1 (el) 2005-07-22 2009-07-03 Μηλεϊκη 3-(2-(διμεθυλαμινο) μεθυλ (κυκλοεξ-1-υλ)) φαινολη και οι κρυσταλλικες μορφες της

Country Status (25)

Country Link
EP (1) EP1881956B1 (enExample)
JP (1) JP5205259B2 (enExample)
KR (1) KR20080033436A (enExample)
CN (1) CN101228110A (enExample)
AR (1) AR057674A1 (enExample)
AT (1) ATE431332T1 (enExample)
AU (1) AU2006271856B2 (enExample)
BR (1) BRPI0614057A2 (enExample)
CA (1) CA2615926A1 (enExample)
CY (1) CY1109208T1 (enExample)
DE (2) DE102005034974A1 (enExample)
DK (1) DK1881956T3 (enExample)
EC (1) ECSP088088A (enExample)
ES (1) ES2326493T3 (enExample)
HR (1) HRP20090412T1 (enExample)
IL (1) IL188897A (enExample)
MX (1) MX2008000743A (enExample)
NO (1) NO20080826L (enExample)
PE (1) PE20070368A1 (enExample)
PL (1) PL1881956T3 (enExample)
PT (1) PT1881956E (enExample)
RU (1) RU2434845C2 (enExample)
SI (1) SI1881956T1 (enExample)
WO (1) WO2007009792A1 (enExample)
ZA (1) ZA200801703B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI384986B (zh) * 2007-01-17 2013-02-11 Lg Life Sciences Ltd 抗病毒劑之順丁烯二酸單鹽以及含有該單鹽之醫藥組成物
SI3173400T1 (sl) * 2007-12-07 2020-01-31 Gruenenthal Gmbh Zdravila, ki vsebujejo kristalinične modifikacije (1R,2R)-3-(3-dimetilamino-1-etil-2-metil-propil)-fenola
EP2085081A1 (de) 2008-02-04 2009-08-05 Grünenthal GmbH 3-(2-Dimethylaminomethyl-cyclohexyl)-phenol gegen polyneuropathischen Schmerz

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE10218862A1 (de) * 2002-04-26 2003-11-06 Gruenenthal Gmbh Verfahren zur Chlorierung tertiärer Alkohole
DE10356362A1 (de) * 2003-11-28 2005-06-23 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen

Also Published As

Publication number Publication date
AR057674A1 (es) 2007-12-12
MX2008000743A (es) 2008-03-10
HK1112612A1 (zh) 2008-09-12
ECSP088088A (es) 2008-02-20
EP1881956A1 (de) 2008-01-30
JP5205259B2 (ja) 2013-06-05
ZA200801703B (en) 2009-08-26
AU2006271856A1 (en) 2007-01-25
SI1881956T1 (sl) 2009-10-31
NO20080826L (no) 2008-02-20
AU2006271856B2 (en) 2012-03-01
PT1881956E (pt) 2009-06-26
ATE431332T1 (de) 2009-05-15
IL188897A (en) 2012-12-31
KR20080033436A (ko) 2008-04-16
DK1881956T3 (da) 2009-09-07
DE502006003728D1 (de) 2009-06-25
ES2326493T3 (es) 2009-10-13
WO2007009792A1 (de) 2007-01-25
RU2434845C2 (ru) 2011-11-27
BRPI0614057A2 (pt) 2012-12-11
HRP20090412T1 (hr) 2009-09-30
PL1881956T3 (pl) 2009-10-30
IL188897A0 (en) 2008-04-13
CA2615926A1 (en) 2007-01-25
JP2009502757A (ja) 2009-01-29
DE102005034974A1 (de) 2007-04-19
PE20070368A1 (es) 2007-05-12
EP1881956B1 (de) 2009-05-13
RU2008106455A (ru) 2009-08-27
CN101228110A (zh) 2008-07-23

Similar Documents

Publication Publication Date Title
AR068369A1 (es) Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina"
PE20090694A1 (es) Compuestos moduladores de sirtuinas
TW200637550A (en) Thiazole-4-carboxamide derivatives as mGluR5 antagonists
CY1114793T1 (el) Παραγωγα αμινοπυραζολιου
BRPI0608732A2 (pt) composto ou um sal, hidrato, solvato, complexo ou pró-droga farmaceuticamente aceitável do mesmo, sal de um composto, processo para a preparação de um composto, uso de um composto, composição farmacêutica, e, produto
CL2007002930A1 (es) Un compuesto 4-[4-({[4-cloro-3-(trifluorometil)fenil]carbamoil}amino)-3-fluorofenoxi]-n-metilpiridin-2-carboxamida monohidratado; proceso de preparacion; composicion y combinacion farmaceutica; y uso para el tratamiento de trastornos hiperproliferati
UY30610A1 (es) Moduladores de mglur5
ECSP099073A (es) Nuevos derivados de piridazina
ATE455110T1 (de) 11-beta-hydroxysteroid-dehydrogenase-1-hemmer
TR201906970T4 (tr) Fenilefrin ihtiva eden sıvı formülasyonlar.
EA200702541A1 (ru) Полиморфы этилового эфира 3-[(2-{[4-(гексилоксикарбониламиноиминометил)фениламино]метил}-1-метил-1н-бензимидазол-5-карбонил)пиридин-2-иламино]пропионовой кислоты
PE20121732A1 (es) Derivados de ciclohexano espiro-condensado como inhibidores de hsl utiles en el tratamiento de la diabetes
CL2009000004A1 (es) Forma cristalina de r-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida; composicion farmaceutica que comprende a dicha forma cristalina; y uso para el tratamiento de diabetes o hiperglicemia.
EA200970019A1 (ru) Кристаллические формы 4-[2-(4-метилфенилсульфанил)фенил]пиперидина с объединенным ингибированием повторного поглощения серотонина и норадреналина для лечения невропатической боли
CL2007001689A1 (es) Formas cristalinas sustancialmente puras de n-hidroxi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil]amino]metil]fenil]-2e-2-propenamida; composicion farmaceutica, util para tratar una enfermedad que responde a una inhibicion de la actividad de cinasa de prot
HN2011002408A (es) Nueva forma cristalina vi de la agomelatina, preparacion y uso de la misma.
UA97660C2 (ru) Жидкие композиции солей 4-[2-(4-метилфенилсульфанил)фенил]-пиперидина
EA201000545A1 (ru) Композиция зиботентана, содержащая маннит и/или микрокристаллическую целлюлозу
CY1109208T1 (el) Μηλεϊκη 3-(2-(διμεθυλαμινο) μεθυλ (κυκλοεξ-1-υλ)) φαινολη και οι κρυσταλλικες μορφες της
SE0401969D0 (sv) Piperidine derivatives
CO6150166A2 (es) Nuevos derivados de [1,3]tiazolo[4,5-d]pirimidin-2-(3h)-amina 5,7-disustituidos y su uso en terapia
ATE502006T1 (de) Alkyl-, alkenyl- und alkynylcarbamat-derivate, deren herstellung und therapeutische verwendung
CR10102A (es) Acido 3-(4-{[4-(4{[3-(3,3,-dimetil-1piperidinil) propil) oxi} fenil)1-piperidinil]carbonil}-1-naftalenil)propanoico o proponeico como antagonistas del receptor h1 h3 para el tratamiento de disfunciones inflamatorias y/o alergicas
EA201000926A1 (ru) Пиперазины в качестве агентов против ожирения
DK1824479T3 (da) Phenylpiperazin-derivater med en kombination af delvis dopamin-D2-receptoragonisme og serotonin-genoptagelsesinhibering